霍奇金淋巴瘤预后因素与风险适应性治疗

Prognosis factors and risk-adapted therapy of Hodgkin lymphoma

霍奇金淋巴瘤(HL)是一种预后较好的恶性淋巴瘤,且随着医疗技术的不断进步,治愈率明显提高。目前面临的主要问题是在提高治愈率的同时,如何根据疾病的病情及预后相关因素升级或降级治疗,即实行风险适应性治疗,减少不良反应,延长患者生存期和提高生命质量。文章重点分析HL预后相关因素、常见的HL治疗方案以及PET-CT结果对实行风险适应性治疗的影响。

Hodgkin lymphoma(HL)is a kind of malignant lymphoma with a good prognosis.With the constant development of medical technology,the cure rate of HL has increased significantly.At present,the main problem is risk-adapted therapy according to the disease condition and prognosis-related factors to increase or decrease the intensity of treatment,in order to increase the cure rate and reduce the side effects,prolong the survival time and improve the quality of life of patients.This article focuses on the analysis of HL prognosis-related factors,common treatment methods for HL,and the effect of PET-CT results on the implementation of risk-adapted therapy.